This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Digital Awards is in its 11th year and celebrates the best in digital communications within the pharmaceutical and healthcare sectors. Let’s hope we can hold the event in person in 2021!”. Patient programmes – Cognitant Group for Bayer LARC patientcounselling tool. category for AbbVie. Still Working!
ARK and Syneos Health Communications top the agency charts. The Digital Awards is in its 11th year and celebrates the best in digital communications within the pharmaceutical and healthcare sectors. Let’s hope we can hold the event in person in 2021!”. Patient programmes. LARC patientcounselling tool.
One of the fundamental components will be patient education and counselling. In United States, concerns regarding improper medication use led to mandates requiring pharmacists to provide patientcounselling and education (e.g. Plan follow-up with the patient, as necessary (if inpatient setting).
The FDA is making this move to “clearly inform patients, caregivers and health care professionals of risks associated with their medications”. The required changes will be made to the prescribing information in the “Warnings and Precautions”, “Drug Abuse and Dependence”, “Overdosage”, and “PatientCounselling” sections.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content